Immune to Cancer: The CRI Blog
-
CRI Received a 100% ‘Four-Star Charity’ Rating – Here’s Why That Matters
When people seek out nonprofits with missions that align with their values, it can be initially challenging… -
Drs. Carl June and Michel Sadelain to Receive 2024 Breakthrough Prize in Life Sciences
CRI Scientific Advisory Council member Carl June, MD (University of Pennsylvania) and CRI Clinical Accelerator Advisor Michel… -
Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative
U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House… -
Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field
iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill… -
Join #TeamCRI and Plan Your Own Tailgate for a Purpose
The Cancer Research Institute (CRI) now has a new way to create a world immune to cancer,… -
CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines
Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first… -
Recent Innovations and Challenges in Fighting Blood Cancers
The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),… -
A CRI Board Member’s Father was Diagnosed with Cancer – He Quickly Raised Over $150,000 for Research
It started with an idea. Yacov Arnopolin wanted to raise money for a cause that was close… -
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.